TumCMig Cancer Research Results
TumCMig, Tumor cell migration: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
Bladder, |
5637 |
|
|
|
TumCD↑, Apoptosis↑, TumCMig↓, TumCP↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
ITGB1↓, TumCMig↓, ERK↓, Akt↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
UMUC3 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
TumCD↑, Apoptosis↑, TumCCA↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK2↓, CDC25↓, mtDam↑, BAX↑, cl‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Snail↓, Slug↓, MMP9↓, selectivity↑, MMP↓, ROS∅, TumCMig↓, TumCI↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCMig↓, Casp↑, TumAuto↑, LC3B-II↑, p‑AMPK↑, mTOR↓, BMI1↓, ROS↑, eff↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
in-vivo, |
RCC, |
A498 |
|
|
|
- |
in-vitro, |
RCC, |
T24/HTB-9 |
|
|
|
- |
NA, |
Bladder, |
5637 |
|
|
|
TRPV1↑, TumCP↓, Casp↑, Apoptosis↑, SIRT1↓, MMP2↓, MMP9↓, TumCMig↓, TumCCA↑, ROS↑, DNAdam↑, PD-L1↑, eff↓,
| - |
vitro+vivo, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
antiOx↑, Inflam↓, AntiCan↓, TRPV1↑, TumCP↓, TumCCA↑, ROS↑, FOXO3↑, TumCMig↓,
| - |
in-vitro, |
Bladder, |
TSGH8301 |
|
|
|
- |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
ENOX2↓, TumCCA↑, ERK↓, p‑FAK↓, p‑pax↓, TumCMig↓, EMT↓, SIRT1↓, Dose∅, ROS↑, MMP↓, Bcl-2↓, Bak↑, cl‑PARP↑, Casp3↑, SIRT1↓, ac‑P53↑, BIM↑, p‑RB1↓, cycD1/CCND1↓, Dose∅, β-catenin/ZEB1↓, N-cadherin↓, E-cadherin↑,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
TumCMig↓, TumCI↓, MMP2↓, MMP9↓, EMT↓, N-cadherin↓, Vim↓, Slug↓, E-cadherin↑, ZO-1↑, p‑SMAD2↓, p‑SMAD3↓, p‑Akt↓, p‑ERK↓, p‑p38↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vivo, |
Bladder, |
NA |
|
|
|
TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, ROS↑, Slug↓, β-catenin/ZEB1↓, Zeb1↓, N-cadherin↓, F-actin↓, GSH↓, EMT↓, CLDN1↓, ZO-1↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
EMT↓, TumCI↓, TumCMig↓, E-cadherin↑, Zeb1↓, Snail↓, COX2↝, MMP2↝, MMP9↝,
Showing Research Papers: 1 to 11 of 11
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, ENOX2↓, 1, GSH↓, 1, PARK2↑, 1, ROS↑, 6, ROS∅, 1,
Mitochondria & Bioenergetics ⓘ
CDC25↓, 1, MMP↓, 3, mtDam↑, 1, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, p‑AMPK↑, 1, SIRT1↓, 3,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 3, Bak↑, 1, BAX↑, 2, Bcl-2↓, 2, Bcl-xL↓, 1, BIM↑, 1, Casp↑, 2, Casp3↑, 2, cl‑Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, p‑p38↓, 1, TRPV1↑, 2, TumCD↑, 2,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Autophagy & Lysosomes ⓘ
LC3B-II↑, 1, LC3II↑, 1, p62↓, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, ac‑P53↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, p‑RB1↓, 1, TumCCA↑, 5,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 2, EMT↓, 4, ERK↓, 2, p‑ERK↓, 1, FOXO3↑, 1, HDAC↓, 1, mTOR↓, 1, mTOR↑, 1, TumCG↓, 1,
Migration ⓘ
CLDN1↓, 1, E-cadherin↑, 4, F-actin↓, 1, p‑FAK↓, 1, ITGB1↓, 1, miR-139-5p↑, 1, MMP2↓, 2, MMP2↝, 1, MMP9↓, 3, MMP9↝, 1, N-cadherin↓, 4, p‑pax↓, 1, Slug↓, 3, p‑SMAD2↓, 1, p‑SMAD3↓, 1, Snail↓, 3, TumCI?, 1, TumCI↓, 4, TumCMig↓, 11, TumCP↓, 5, TumMeta↓, 1, Vim↓, 2, Zeb1↓, 2, ZO-1↓, 1, ZO-1↑, 1, β-catenin/ZEB1↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↝, 1, Inflam↓, 1, PD-L1↑, 1,
Drug Metabolism & Resistance ⓘ
Dose∅, 2, eff↓, 3, selectivity↑, 1,
Clinical Biomarkers ⓘ
PD-L1↑, 1,
Functional Outcomes ⓘ
AntiCan↓, 1, AntiTum↑, 1,
Total Targets: 87
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCMig, Tumor cell migration
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:326 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page